Driver site

Driver launches its platform to connect cancer patients to the best treatments

The new service enables patients, anywhere in the world, to access treatment options across a network of cancer centers without leaving home.
Flatiron Health

Roche acquires maker of the oncology-specific EHR Flatiron Health for $1.9B

Acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of health data and analytics.
NAVIFY Tumor Board

Accenture, Roche working together to enhance digital healthcare for cancer patients

Under the deal, Accenture will provide digital data integration services to Roche's NAVIFY Tumor Board solution.
BiliScreen app

An app uses smartphone’s camera to screen for pancreatic cancer

Called BiliScreen, it relies on computer vision algorithms and machine learning tools to detect increased bilirubin levels in a person's sclera.
Sunface app

This selfie app aims to prevent skin cancer

The Sunface app photoages the user's skin based on skin type and individual UV-protection behavior.
Eva bra

Mexican student invents cancer-detecting bra

The device uses two hundred small tactile biosensors that map the surface of the breast and monitor changes in texture, color and temperature.
Belong app

This app helps cancer patients control their treatment journey

One of the app features helps to manage, and track appointments, treatments, goals, tips, information, and what has worked for others in similar situations.
Fitbit Charge HR

New study uses Fitbit to test if weight loss can prevent breast cancer recurrence

The Breast Cancer Weight Loss (BWEL) study will enroll nearly 3,200 overweight and obese women with early stage breast cancer.
Honor app

Honor adds cancer care to its caregiver services program

The company's will license American Cancer Society's care guidance so that its Care Pros can give specialized care to clients diagnosed with cancer.
Fitbit Charge HR

Cedars-Sinai to use Fitbit Charge HR in a small trial of cancer patients

Researchers want to use the activity tracker to determine if it can help oncologists assess whether their patients are active enough for chemotherapy.